HEADER HORMONE 19-JUL-18 6H3M TITLE THE CRYSTAL STRUCTURE OF A HUMAN SELENO-INSULIN ANALOG COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN; COMPND 3 CHAIN: A, C, E, G, I, K, N, R; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: INSULIN; COMPND 7 CHAIN: B, D, F, H, J, L, P, Q; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606 KEYWDS INSULIN, SELENOCYSTEINE, ANALOG, HUMAN, HORMONE EXPDTA X-RAY DIFFRACTION AUTHOR S.LANSKY,O.WEIL-KTORZA,N.METANIS,G.SHOHAM REVDAT 2 26-AUG-20 6H3M 1 JRNL LINK REVDAT 1 14-AUG-19 6H3M 0 JRNL AUTH O.WEIL-KTORZA,N.REGE,S.LANSKY,D.E.SHALEV,G.SHOHAM,M.A.WEISS, JRNL AUTH 2 N.METANIS JRNL TITL SUBSTITUTION OF AN INTERNAL DISULFIDE BRIDGE WITH A JRNL TITL 2 DISELENIDE ENHANCES BOTH FOLDABILITY AND STABILITY OF HUMAN JRNL TITL 3 INSULIN. JRNL REF CHEMISTRY V. 25 8513 2019 JRNL REFN ISSN 0947-6539 JRNL PMID 31012517 JRNL DOI 10.1002/CHEM.201900892 REMARK 2 REMARK 2 RESOLUTION. 1.82 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.12_2829: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.970 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 28475 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1422 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.9892 - 3.9224 0.99 2762 146 0.1743 0.2005 REMARK 3 2 3.9224 - 3.1139 0.99 2792 147 0.1730 0.1979 REMARK 3 3 3.1139 - 2.7205 0.98 2749 145 0.1944 0.2388 REMARK 3 4 2.7205 - 2.4718 0.97 2705 142 0.1940 0.2757 REMARK 3 5 2.4718 - 2.2947 0.97 2722 143 0.1949 0.2242 REMARK 3 6 2.2947 - 2.1594 0.97 2747 145 0.1924 0.2709 REMARK 3 7 2.1594 - 2.0513 0.96 2683 140 0.2046 0.2586 REMARK 3 8 2.0513 - 1.9620 0.96 2722 143 0.2230 0.2812 REMARK 3 9 1.9620 - 1.8864 0.96 2696 142 0.2573 0.2997 REMARK 3 10 1.8864 - 1.8213 0.88 2475 129 0.2863 0.3407 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.420 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.013 3277 REMARK 3 ANGLE : 1.491 4433 REMARK 3 CHIRALITY : 0.089 486 REMARK 3 PLANARITY : 0.009 566 REMARK 3 DIHEDRAL : 12.807 1908 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6H3M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-JUL-18. REMARK 100 THE DEPOSITION ID IS D_1200010860. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-JUN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28501 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.820 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : 5.220 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.6700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.04 REMARK 200 R MERGE FOR SHELL (I) : 0.72100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.670 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 31.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.8 M NACL, 35 MM NACITRATE, 0.5 MM REMARK 280 ZNACETATE, 0.3 M TRIS PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6, 7, 8 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: F, K REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 7 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: N, Q REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 8 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: P, R REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR B 30 REMARK 465 THR F 30 REMARK 465 THR H 30 REMARK 465 PHE J 1 REMARK 465 VAL J 2 REMARK 465 PHE Q 1 REMARK 465 VAL Q 2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU E 4 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL B 2 -61.64 -130.14 REMARK 500 ASN F 3 -2.99 78.78 REMARK 500 LYS L 29 74.06 -66.34 REMARK 500 SER G 9 -168.98 -102.84 REMARK 500 SER N 9 -166.20 -103.31 REMARK 500 SER R 9 -168.11 -101.47 REMARK 500 REMARK 500 REMARK: NULL DBREF 6H3M A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 6H3M B 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 6H3M C 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 6H3M D 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 6H3M F 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 6H3M H 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 6H3M J 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 6H3M L 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 6H3M E 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 6H3M G 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 6H3M I 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 6H3M K 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 6H3M N 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 6H3M P 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 6H3M Q 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 6H3M R 1 21 UNP P01308 INS_HUMAN 90 110 SEQADV 6H3M SEC A 6 UNP P01308 CYS 95 ENGINEERED MUTATION SEQADV 6H3M SEC A 11 UNP P01308 CYS 100 ENGINEERED MUTATION SEQADV 6H3M SEC C 6 UNP P01308 CYS 95 ENGINEERED MUTATION SEQADV 6H3M SEC C 11 UNP P01308 CYS 100 ENGINEERED MUTATION SEQADV 6H3M SEC E 6 UNP P01308 CYS 95 ENGINEERED MUTATION SEQADV 6H3M SEC E 11 UNP P01308 CYS 100 ENGINEERED MUTATION SEQADV 6H3M SEC G 6 UNP P01308 CYS 95 ENGINEERED MUTATION SEQADV 6H3M SEC G 11 UNP P01308 CYS 100 ENGINEERED MUTATION SEQADV 6H3M SEC I 6 UNP P01308 CYS 95 ENGINEERED MUTATION SEQADV 6H3M SEC I 11 UNP P01308 CYS 100 ENGINEERED MUTATION SEQADV 6H3M SEC K 6 UNP P01308 CYS 95 ENGINEERED MUTATION SEQADV 6H3M SEC K 11 UNP P01308 CYS 100 ENGINEERED MUTATION SEQADV 6H3M SEC N 6 UNP P01308 CYS 95 ENGINEERED MUTATION SEQADV 6H3M SEC N 11 UNP P01308 CYS 100 ENGINEERED MUTATION SEQADV 6H3M SEC R 6 UNP P01308 CYS 95 ENGINEERED MUTATION SEQADV 6H3M SEC R 11 UNP P01308 CYS 100 ENGINEERED MUTATION SEQRES 1 A 21 GLY ILE VAL GLU GLN SEC CYS THR SER ILE SEC SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 B 30 THR PRO LYS THR SEQRES 1 C 21 GLY ILE VAL GLU GLN SEC CYS THR SER ILE SEC SER LEU SEQRES 2 C 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 D 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 D 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 D 30 THR PRO LYS THR SEQRES 1 F 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 F 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 F 30 THR PRO LYS THR SEQRES 1 H 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 H 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 H 30 THR PRO LYS THR SEQRES 1 J 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 J 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 J 30 THR PRO LYS THR SEQRES 1 L 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 L 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 L 30 THR PRO LYS THR SEQRES 1 E 21 GLY ILE VAL GLU GLN SEC CYS THR SER ILE SEC SER LEU SEQRES 2 E 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 G 21 GLY ILE VAL GLU GLN SEC CYS THR SER ILE SEC SER LEU SEQRES 2 G 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 I 21 GLY ILE VAL GLU GLN SEC CYS THR SER ILE SEC SER LEU SEQRES 2 I 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 K 21 GLY ILE VAL GLU GLN SEC CYS THR SER ILE SEC SER LEU SEQRES 2 K 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 N 21 GLY ILE VAL GLU GLN SEC CYS THR SER ILE SEC SER LEU SEQRES 2 N 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 P 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 P 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 P 30 THR PRO LYS THR SEQRES 1 Q 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 Q 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 Q 30 THR PRO LYS THR SEQRES 1 R 21 GLY ILE VAL GLU GLN SEC CYS THR SER ILE SEC SER LEU SEQRES 2 R 21 TYR GLN LEU GLU ASN TYR CYS ASN FORMUL 17 HOH *140(H2 O) HELIX 1 AA1 GLY A 1 CYS A 7 1 7 HELIX 2 AA2 SER A 12 ASN A 18 1 7 HELIX 3 AA3 GLY B 8 GLY B 20 1 13 HELIX 4 AA4 GLU B 21 GLY B 23 5 3 HELIX 5 AA5 ILE C 2 CYS C 7 1 6 HELIX 6 AA6 SER C 12 CYS C 20 5 9 HELIX 7 AA7 CYS D 7 GLY D 20 1 14 HELIX 8 AA8 GLU D 21 GLY D 23 5 3 HELIX 9 AA9 CYS F 7 GLY F 20 1 14 HELIX 10 AB1 GLU F 21 GLY F 23 5 3 HELIX 11 AB2 GLY H 8 GLY H 20 1 13 HELIX 12 AB3 GLU H 21 GLY H 23 5 3 HELIX 13 AB4 CYS J 7 GLY J 20 1 14 HELIX 14 AB5 GLU J 21 GLY J 23 5 3 HELIX 15 AB6 GLY L 8 GLY L 20 1 13 HELIX 16 AB7 GLU L 21 GLY L 23 5 3 HELIX 17 AB8 ILE E 2 CYS E 7 1 6 HELIX 18 AB9 SER E 12 CYS E 20 5 9 HELIX 19 AC1 ILE G 2 CYS G 7 1 6 HELIX 20 AC2 TYR G 14 CYS G 20 5 7 HELIX 21 AC3 ILE I 2 CYS I 7 1 6 HELIX 22 AC4 SER I 12 GLU I 17 1 6 HELIX 23 AC5 ASN I 18 CYS I 20 5 3 HELIX 24 AC6 ILE K 2 CYS K 7 1 6 HELIX 25 AC7 SER K 12 CYS K 20 5 9 HELIX 26 AC8 ILE N 2 CYS N 7 1 6 HELIX 27 AC9 SER N 12 ASN N 18 1 7 HELIX 28 AD1 GLY P 8 GLY P 20 1 13 HELIX 29 AD2 GLU P 21 GLY P 23 5 3 HELIX 30 AD3 CYS Q 7 GLY Q 20 1 14 HELIX 31 AD4 GLU Q 21 GLY Q 23 5 3 HELIX 32 AD5 ILE R 2 CYS R 7 1 6 HELIX 33 AD6 SER R 12 GLU R 17 1 6 HELIX 34 AD7 ASN R 18 CYS R 20 5 3 SHEET 1 AA1 2 PHE B 24 TYR B 26 0 SHEET 2 AA1 2 PHE P 24 TYR P 26 -1 O PHE P 24 N TYR B 26 SHEET 1 AA2 2 PHE H 24 TYR H 26 0 SHEET 2 AA2 2 PHE L 24 TYR L 26 -1 O PHE L 24 N TYR H 26 SSBOND 1 CYS A 7 CYS J 7 1555 1555 2.04 SSBOND 2 CYS A 20 CYS J 19 1555 1555 2.06 SSBOND 3 CYS B 7 CYS E 7 1555 1555 2.03 SSBOND 4 CYS B 19 CYS E 20 1555 1555 2.03 SSBOND 5 CYS C 7 CYS D 7 1555 1555 2.03 SSBOND 6 CYS C 20 CYS D 19 1555 1555 2.04 SSBOND 7 CYS F 7 CYS K 7 1555 1555 2.03 SSBOND 8 CYS F 19 CYS K 20 1555 1555 2.04 SSBOND 9 CYS H 7 CYS G 7 1555 1555 2.04 SSBOND 10 CYS H 19 CYS G 20 1555 1555 2.03 SSBOND 11 CYS L 7 CYS I 7 1555 1555 2.04 SSBOND 12 CYS L 19 CYS I 20 1555 1555 2.04 SSBOND 13 CYS N 7 CYS Q 7 1555 1555 2.04 SSBOND 14 CYS N 20 CYS Q 19 1555 1555 2.04 SSBOND 15 CYS P 7 CYS R 7 1555 1555 2.05 SSBOND 16 CYS P 19 CYS R 20 1555 1555 2.02 LINK SE SEC A 6 SE SEC A 11 1555 1555 2.34 LINK SE SEC C 6 SE SEC C 11 1555 1555 2.33 LINK SE SEC E 6 SE SEC E 11 1555 1555 2.65 LINK SE SEC G 6 SE SEC G 11 1555 1555 2.67 LINK SE SEC I 6 SE SEC I 11 1555 1555 2.41 LINK SE SEC K 6 SE SEC K 11 1555 1555 2.36 LINK SE SEC N 6 SE SEC N 11 1555 1555 2.39 LINK SE SEC R 6 SE SEC R 11 1555 1555 2.43 CRYST1 39.011 42.344 61.453 100.58 98.70 117.43 P 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025634 0.013305 0.008112 0.00000 SCALE2 0.000000 0.026608 0.008025 0.00000 SCALE3 0.000000 0.000000 0.017195 0.00000